Business, energy, technology, markets and global industry news from Business News Today

AVLAYAH

Features & Analysis

Why the blood-brain barrier keeps powerful drugs out of the brain and how brain shuttles are starting to break through

The blood-brain barrier protects neurons by tightly controlling molecular traffic, but the same biology excludes many antibodies, enzymes and nucleic-acid medicines. Drug developers are increasingly hijacking the barrier’s own transport systems rather than trying simply to disrupt it.

Read More
Pharma & Biotech

Denali monetises its FDA voucher as AVLAYAH enters a critical confirmatory phase

Denali Therapeutics is converting AVLAYAH’s regulatory reward into non-dilutive capital for its blood-brain barrier pipeline, but clinical and commercial risks remain.

Read More